CAM and cancer
- Conditions
- Chemotherapy.Disorders of initiating and maintaining sleep
- Registration Number
- IRCT2017061134457N1
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Criteria for inclusion in the study: lack of stressful events such as near-death or surgery in the last six months; age range from 18 to 60 years old; having the consent to participate in the study; do not use the herbal remedy in the past month; not having allergic rhinitis, asthma, chronic pulmonary disease, sleep disorders and other chronic diseases that affect the sense of smell; lack of susceptibility to medicinal herbs' not using sleeping pills; take minimum 3-day course of chemotherapy.
Exclusion criteria: occurrence of stressful events: close lives, divorces and ... during the study; unwillingness to continue cooperation in the study; use sleep palliative interventions during the study; symptoms of allergy to the fragrance used; having pain during the study (indicated by the patient's question).
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sleep quality. Timepoint: Before and 1-3 nights during the intervention. Method of measurement: Standard sleep quality questionnaire.
- Secondary Outcome Measures
Name Time Method